Food restriction and fish oil suppress atherogenic risk factors in lupus-prone (NZB x NZW) F1 mice

Journal of Clinical Immunology

Volumn 23, Issue 1, 2003, Pages 23-33

  Muthukumar, Alagarraju ^a   Zaman, Khaliquz ^a   Lawrence, Richard ^a   Barnes, Jeffery L ^a   Fernandes, Gabriel ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Atherogenesis; Autoimmunity; Fish oil; Food restriction; Hypercholesterolemia; Hyperlipidemia; Lupus nephritis; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CHOLESTEROL; DNA ANTIBODY; DOUBLE STRANDED DNA; FISH OIL; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; ATHEROGENESIS; BLOOD VESSEL; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; LEUKOCYTE; MESANGIUM; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ARTERIOSCLEROSIS; CALORIC RESTRICTION; CHOLESTEROL; DNA; FISH OILS; IMMUNOGLOBULIN G; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED NZB;

EID: 0037286229     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021996130672     Document Type: Article

References (62)

1. Karrar A, Sequeira W. Block JA: Coronary artery disease in systemic lupus erythematosus: A review of the literature. Semin Arthritis Rheum 30:436-443, 2001
2. Petri M, Perez-Gutthann S, Spence D, Hochberg MC: Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513-519, 1992
3. Andany MA, Kasiske BL: Dyslipidemia and its management after renal transplantation. J Nephrol 14 Suppl 4:S81-88, 2001
4. Baum CL, Thielke K, Westin E, Kogan E, Cicalese L, Benedetti E: Predictors of weight gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients. Nutrition 18:139-146, 2002
5. Wierzbicki AS: The role of lipid lowering in transplantation. Int J Clin Pract 53:54-59, 1999
6. Kobashigawa JA, Kasiske BL: Hyperlipidemia in solid organ transplantation. Transplantation 63:331-338, 1997
7. Arnadottir M, Berg AL: Treatment of hyperlipidemia in renal transplant recipients. Transplantation 63:339-345, 1997
8. Zuckerman E, Toubi E, Shiran A, Sabo E, Shmuel Z, Golan TD, Abinader E, Yeshurun D: Anticardiolipin antibodies and acute myocardial infarction in nonsystemic lupus erythmatosus patients: A controlled prospective study. Am J Med 101:381-386, 1996
9. Gogos CA, Skoutelis A, Kalfarentzos F: The effects of lipids on the immune response of patients with cancer. J Nutr Health Aging 4:172-175, 2000
10. Iso H, Rexrode KM, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Hennekens CH, Willett WC: Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 285:304-312, 2001
11. James MJ, Cleland LG: Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum 27:85-97, 1997
12. Yamada T, Strong JP, Ishii T, Ueno T, Koyama M, Wagayama H, Shimizu A, Sakai T, Malcom GT, Guzman MA: Atherosclerosis and omega-3 fatty acids in the populations of a fishing village and a faring village in Japan. Atherosclerosis 153:469-481, 2000
13. Das UN: Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: But, why and how? Prostaglandins Leukot Essent Fatty Acids 63:351-362, 2000
14. Fernandes G: Effect of calorie restriction and omega-3 fatty acids on autoimmunity and aging. Nutr Rev 53:S72-S79, 1995
15. Troyer DA, Chandrasekar B, Thinnes T, Stone A, Loskutoff DA, Fernandes G: Effects of energy intake on type I plasminogen activator inhibitor levels in glomeruli of lupus-prone B/W mice. Am J Pathol 146:111-120, 1995
16. Mizutani H, Kurata Y, Kosugi S, Shiraga M, Kashiwagi H, Tomiyama Y, Kanakura Y, Good RA, Matsuzawa Y: Monoclonal anticardiolipin autoantibodies established from the (New Zealand white x BXSB)F1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipoprotein. Arthritis Rheum 38:1382-1388, 1995
17. Theofilopoulos AN, Kofler R, Singer PA, Dixon FJ: Molecular genetics of murine lupus models. Adv Immunol 46:61-109, 1989
18. McNeil HP, Chesterman CN, Krilis SA: Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49:193-280, 1991
19. Roubey RA: Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 84:2854-2867, 1994
20. Vaarala O, Puurunen M, Lukka M, Alfthan G, Leirisalo-Repo M, Aho K, Palosuo T: Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein. Clin Exp Immunol 104:269-274, 1996
21. Vaarala O: Antiphospholipid antibodies and myocardial infarction. Lupus 7:S132-134, 1998
22. Fernandes G, Good RA: Inhibition by restricted-calorie diet of lymphoproliferative disease and renal damage in MRL/lpr mice. Proc Natl Acad Sci USA 81:6144-6148, 1984
23. Fernandes G, Bysani C, Venkatraman JT, Tomar V, Zhao W: Increased TGF-beta and decreased oncogene expression by omega-3 fatty acids in the spleen delays onset of autoimmune disease in B/W mice. J Immunol 152:5979-5987, 1994
24. Jolly C, Muthukumar A, Reddy Avula C, Troyer D, Fernandes G: Life span is prolonged in food-restricted autoimmune-prone (NZB x NZW)F(1) mice fed a diet enriched with (n-3) fatty acids. J Nutr 131:2753-2760, 2001
25. Muthukumar AR, Jolly CA, Zaman K, Fernandes G: Calorie restriction decreases proinflammatory cytokines and polymeric Ig receptor expression in the submandibular glands of autoimmune prone (NZB x NZW)F1 mice. J Clin Immunol 20:354-361, 2000
26. Jolly CA, Fernandes G: Diet modulates Th-1 and Th-2 cytokine production in the peripheral blood of lupus-prone mice. J Clin Immunol 19:172-178, 1999
27. Barnes JL, Hastings RR, De la Garza MA: Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis. Am J Pathol 145:585-589, 1994
28. Hornbeck P: Antibody detection and preparation. In Current Protocols in Immunology, Colligan J, Krusbeek A, Margulies D, Shevach E, Strober W (eds). New York, John Wiley & Sons, 1992, pp 231-234
29. Norris MS, McConnell TJ, Mannie MD: Interleukin-2 promotes antigenic reactivity of rested T cells but prolongs the postactivational refractory phase of activated T cells. Cell Immunol 211:51-60, 2001
30. Rahman P, Gladman DD, Urowitz MB, Yuen K, Hallett D, Bruce IN: The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs. J Rheumatol 26:325-330, 1999
31. Wallace DJ, Metzger AL, Stecher VJ, Turnbull BA, Kern PA: Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: Reversal of deleterious effects of steroids on lipids. Am J Med 89:322-326, 1990
32. Ilowite NT, Copperman N, Leicht T, Kwong T, Jacobson MS: Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus. J Rheumatol 22:1347-1351, 1995
33. Chang SC, Chiang BL, Wu WM, Lin BF: Different dietary fats influence serum and tissue lipids and anti-cardiolipin antibody levels in autoimmune-prone NZB/W F1 mice. Br J Nutr 81:331-340, 1999
34. Kannel WB, Castelli WP. Gordon T, McNamara PM: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 74:1-12, 1971
35. Manzi S, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie JE, Tracy RP, Kuller LH: Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 42:51-60, 1999
36. Leong KH, Koh ET, Feng PH, Boey ML: Lipid profiles in patients with systemic lupus erythematosus. J Rheumatol 21:1264-1267, 1994
37. Hearth-Holmes M, Baethge BA, Broadwell L, Wolf RE: Dietary treatment of hyperlipidemia in patients with systemic lupus erythematosus. J Rheumatol 22:450-454, 1995
38. Hung P, Gu JY, Kaku S, Yunoki S, Ohkura K, Ikeda I, Tachibana H, Sugano M, Yazawa K, Yamada K: Dietary effects of eicosapentaenoic and docosahexaenoic acid esters on lipid metabolism and immune parameters in Sprague-Dawley rats. Biosci Biotechnol Biochem 64:2588-2593, 2000
39. Harris WS: Fish oil and plasma lipid and lipoprotein metabolism in humans: A critial review. J Lipid Res 30:785-807, 1989
40. Clark WF, Parbtani A, Naylor CD, Levinton CM, Muirhead N, Spanner E, Huff MW, Philbrick DJ, Holub BJ: Fish oil in lupus nephritis: Clinical findings and methodological implications. Kidney Int 44:75-86, 1993
41. Leon TI, Lim BO, Yu BP, Lim Y, Jeon EJ, Park DK: Effect of dietary restriction on age-related increase of liver susceptibility to peroxidation in rats. Lipids 36:589-593, 2001
42. Verdery RB, Ingram DK, Roth GS, Lane MA: Caloric restriction increases HDL2 levels in rhesus monkeys (Macaca mulatta). Am J Physiol 273:E714-719, 1997
43. Choi YS, Goto S, Ikeda I, Sugano M: Age-related changes in lipid metabolism in rats: The consequence of moderate food restriction. Biochim Biophys Acta 963:237, 1988
44. Hubert MF, Laroque P, Gillet JP, Keenan KP: The effects of diet, ad libitum feeding, and moderate and severe dietary restriction on body weight, survival, clinical pathology parameters, and cause of death in control Sprague-Dawley rats. Toxicol Sci 58:195-207, 2000
45. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809, 1993
46. Steinberg D, Parthasarathy S, Crew TE, Khoo JC, Witztum JL: Beyond cholesterol: Modification of low density lipoproteins that increases its atherogenicity. N Engl J Med 320:915-924, 1989
47. Libby P, Hansson GK: Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions. Lab Invest 64:5-15, 1991
48. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q: Is atherosclerosis an immunologically mediated disease? Immunol Today 16:27-33, 1995
49. Kishikawa H, Shimokama T, Watanabe T: Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis. Virchows Arch A Pathol Anat Histopathol 423:433-442, 1993
50. van der Wal AC, Das PK, Bentz van de Berg D, van der Loos CM, Becker AE: Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 61:166-170, 1989
51. Adams DH, Shaw S: Leucocyte-endothelial interactions and regulation of leucocyte migration [see comments]. Lancet 343:831-836, 1994
52. Kabakov A, Tertov V, Saenko V, Poverenny A, Orekhov A: The atherogenic effect of lupus sera: Systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta. Clin Immunol 63:214-220, 1992
53. George J, Blank M, Levy Y, Meroni P, Damianovich M, Tincani A, Shoenfeld Y: Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 97:900-906, 1998
54. Ameli S, Hultgardh-Nilsson A, Regnstrom J, Calara F, Yano J, Cercek B, Shah PK, Nilsson J: Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 16:1074-1079, 1996
55. Witztum JL: The oxidation hypothesis of atherosclerosis. Lancet 344:793-795, 1994
56. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL: Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883-887, 1992
57. Palinski W, Yla-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL: Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10:325-335, 1990
58. Matsuura E, Kobayashi K, Yasuda T, Koike T: Antiphospholipid antibodies and atherosclerosis. Lupus 7:S135-139, 1998
59. George J, Blank M, Hojnik M, Bar-Meir E, Koike T, Matsuura E, Lorber M, Aviram M, Shoenfeld Y: Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS). Clin Exp Immunol 108:227-233, 1997
60. Vaarala O, Alfthan G, Jauhiainen M, Leirisalo-Repo M, Aho K, Palosuo T: Cross-reaction between antibodies to oxidised lowdensity lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 341:923-925, 1993
61. + suppressor T cells. Immunol Rev 182:58-67, 2001
62. + regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182:18-32, 2001